Psychedelic Stocks

COMPASS Pathways launches proposed public offering

Compass Pathways plans to issue 4,000,000 new shares via prospectus, with an option to sell an additional 600,000 shares.

04/28/2021 PSW Editor

Optimi Health Finalizes Planned Build-Out of Mushroom Production and Research Facility

Optimi Health gets closer to completion of its 20,000 sq. ft. production and research facility in British Columbia.

04/27/2021 PSW Editor

Psyched Wellness Initiates the Next Pre-Clinical Trial Study on AME-1

Psyched Wellness continues pre-clinical work on its AME-1 extract.

04/27/2021 PSW Editor

MindMed Begins Trading on Nasdaq

MindMed Inc commences trading on the NASDAQ exchange under the symbol "MNMD".

04/27/2021 PSW Editor

Red Light Holland and Halo Collective Create Red Light Oregon, Inc. - Forwarding Intentions to Enter Oregon Medicinal Psychedelic Market

Red Light Holland seeks to enter the (legal) medicinal psilocybin market in Oregon.

04/27/2021 PSW Editor

Second-Chance Buying Opportunity With Psychedelic Stock Warrants

In 2020, investors were able to reap spectacular returns from psychedelic stock warrants. With a new rally starting in the sector, a there is a NEW opportunity in these warrants.

04/27/2021 Jeff Nielson

Numinus Announces Phase 1 Clinical Trial of Natural Psilocybin Mushroom Extraction Prepared at Company Lab

Numinus' Phase I clinical trial will evaluate safety/tolerance properties of its Psilocybe mushroom product.

04/26/2021 PSW Editor

Drug Reform: Record (91%) American Support For Legalizing Medicinal Cannabis

U.S. support for legalizing cannabis for medicinal use has hit a new record-high: 91%. Strong bipartisan support. Next: psychedelic drugs.

04/26/2021 Jeff Nielson

Champignon Brands Announces Revocation of Cease Trade Orders

Champignon Brands has had its Cease Trade Order lifted and can resume trading on the CSE effective April 23, 2021 (symbol: SHRM).

04/23/2021 PSW Editor

MindMed To Commence Trading on Nasdaq

MindMed Inc (CAN:MMED / US:MMEDF) has received approval to commence trading on the NASDAQ starting April 27th. Symbol: MNMD.

04/23/2021 PSW Editor

Countdown To The atai IPO Begins: atai Files For $100m IPO Financing

With atai Life Sciences filing for a $100 million IPO financing, the countdown to IPO day has begun.

04/22/2021 Jeff Nielson

Cybin Demonstrates Proof of Concept of Its Deuterated Tryptamines for the Treatment of Depression and Addiction

Cybin has successfully demonstrated proof of concept for two new drug candidates in internal testing as it moves toward IND status.

04/21/2021 PSW Editor